Publications

5600 Results

Tumor infiltrating lymphocytes and PD-L1 expression in pre- and post-treatment breast cancers in the SWOG S0800 Phase II neoadjuvant chemotherapy trial

Authors
V Pelekanou;W Barlow;Z Nahleh;B Wasserman;Y-C Lo;M-K von Wahlde;D Hayes;G Hortobagyi;J Gralow;D Tripathy;P Porter;RB Livingston;B Szekely;C Hatzis;DL Rimm;L Pusztai
Journal / Conference
Molecular Cancer Therapeutics Jun;17(6):1324-1331; Mar 27 [Epub ahead of print]
Year
2018
Research Committee(s)
Breast
PMID
PMID29588392
PMC
PMC6548451
Study Number(s)
S0800

Circulating microRNAs and treatment response in SWOG S0925, a randomized phase II study of androgen deprivation combined with cixutumumab versus androgen deprivation alone for patients with new metastatic hormone-sensitive prostate cancer

Authors
H Cheng;M Plets;H Li;C Higano;C Tangen;N Agarwal;N Vogelzang;M Hussain;I Thompson;M Tewari;EY Yu
Journal / Conference
Prostate Feb;78(2):121-127
Year
2018
Research Committee(s)
Genitourinary
PMID
PMID29105802
PMC
PMC5728359
Study Number(s)
S0925

Circadian Genes and Risk of Prostate Cancer in the Prostate Cancer Prevention Trial

Authors
LW Chu;C Till;B Yang;C Tangen;P Goodman;K Yu;Y Zhu;S Han;A Hoque;C Ambrosone;I Thompson;R Leach;A Hsing
Journal / Conference
Molecular Carcinogenesis Mar;57(3):462-466; Jan 10 [Epub ahead of print]
Year
2018
Research Committee(s)
Cancer Control
PMID
PMID29318656
PMC
PMC5840353
Study Number(s)
SWOG-9217

Patient-reported outcomes for patients with metastatic castration-resistant prostate cancer receiving docetaxel and Atrasentan versus docetaxel and placebo in a randomized phase III clinical trial (SWOG S0421)

Authors
J Unger;K Griffin;GW Donaldson;K Baranowski;M Good;P Twardowski;P Van Veldhuizen;M Hussain;C Higano;PN Lara;C Tangen;DI Quinn;JL Wade;N Vogelzang;IM Thompson;C Moinpour
Journal / Conference
Journal of Patient-Reported Outcomes
Year
2018
Research Committee(s)
Genitourinary
PMID
PMID29951640
PMC
PMC5997724
Study Number(s)
S0421

Continued excellent outcomes in previously untreated follicular lymphoma patients after treatment with CHOP plus Rituximab or CHOP plus 131Iodine-Tositumomab - long term follow-up of phase III randomized study SWOG-S0016

Authors
M Shadman;H Li;L Rimsza;JP Leonard;MS Kaminski;R Braziel;C Spier;AK Gopal;DG Maloney;BD Cheson;S Dakhil;M LeBlanc;SM Smith;RI Fisher;JW Friedberg;OW Press
Journal / Conference
Journal of Clinical Oncology, Mar 1;36(7):697-703; Jan 22 [Epub ahead of print]
Year
2018
Research Committee(s)
Lymphoma
PMID
PMID29356608
PMC
PMC Journal - In Process
Study Number(s)
S0016

Duration of Adjuvant Chemotherapy for Stage III Colon Cancer

Authors
A Grothey;A Sobrero;A Shields;T Yoshino;J Paul;J Taieb;I Souglakos;Q Shi;R Kerr;R Labianca;J Meyerhardt;D Vernerey;T Yamanaka;I Boukovinas;JP Meyers;LA Renfro;D Niedzwiecki;V Torri;D Sargent;T Andre;T Iveson
Journal / Conference
New England Journal of Medicine Mar 29;378(13):1177-1188
Year
2018
Research Committee(s)
Gastrointestinal
PMID
PMID29590544
PMC
PMC6426127
Study Number(s)
CTSU/C80702

Association of Survival With Adherence to the American Cancer Society Nutrition and Physical Activity Guidelines for Cancer Survivors After Colon Cancer Diagnosis: The CALGB 89803/Alliance Trial

Authors
E Van Blarigan;C Fuchs;D Niedzwiecki;X Ye;S Zhang;L Saltz;R Mayer;R Mowat;R Whittom;A Hantel;A Benson;D Atienza;M Messino;H Kindler;A Venook;S Ogino;E Giovannucci;K Ng;J Meyerhardt
Journal / Conference
JAMA Oncology Jun 1;4(6):783-790; Apr 12. doi: 10.1001/jamaoncol.2018.0126. [Epub ahead of print]
Year
2018
Research Committee(s)
Gastrointestinal
PMID
PMID29710284
PMC
PMC6145685
Study Number(s)
C89803

A phase Ib/II randomized study of mfolfirinox (mffox) + pegylated recombinant human hyaluronidase (pegph20) versus mffox alone in patients with good performance status metastatic pancreatic adenocarcinoma (mPC): SWOG S1313 (NCT #01959139)

Authors
R Ramanathan;S McDonough;PA Philip;S Hingorani;J Kortmansky;J Thumar;EG Chiorean;AF Shields;D Behl;P Mehan;R Gaur;T Seery;K Guthrie;H Hochster
Journal / Conference
Journal of Clinical Oncology 36(suppl 4S; abstr 208); ASCO Gastrointestinal Cancers Symposium 2018 (January 18-20, 2018, San Francisco, CA), poster session
Year
2018
Research Committee(s)
Gastrointestinal
Study Number(s)
S1313

Effect of Acupuncture vs Sham Acupuncture or Waitlist Control on Joint Pain Related to Aromatase Inhibitors Among Women With Early-Stage Breast Cancer: A Randomized Clinical Trial

Authors
D Hershman;J Unger;H Greenlee;J Capodice;D Lew;A Darke;A Kengla;M Melnik;C Jorgensen;W Kreisle;L Minasian;M Fisch;NL Henry;K Crew
Journal / Conference
JAMA Jul 10;320(2):167-176
Year
2018
Research Committee(s)
Symptom Management and Survivorship
PMID
PMID29998338
PMC
PMC6583520
Study Number(s)
S1200

A Phase III IntergroupTrial of Adjuvant Androgen Deprivation +/- Mitoxantrone + Prednisone in Patients with High-Risk Prostate Cancer Post-Radical Prostatectomy: SWOG S9921

Authors
M Hussain;C Tangen;I Thompson;G Swanson;DP Wood;W Sakr;N Dawson;N Haas;T Flaig;T Dorff;DW Lin;ED Crawford;DI Quinn;N Vogelzang
Journal / Conference
Journal of Clinical Oncology May 20;36(15):1498-1504; Apr 6 [Epub ahead of print]
Year
2018
Research Committee(s)
Genitourinary
PMID
PMID29624463
PMC
PMC5959197
Study Number(s)
S9921